3,072 Shares in Agilent Technologies, Inc. (NYSE:A) Bought by William B. Walkup & Associates Inc.

William B. Walkup & Associates Inc. bought a new position in shares of Agilent Technologies, Inc. (NYSE:A) in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm bought 3,072 shares of the medical research company’s stock, valued at approximately $398,000.

Several other large investors have also bought and sold shares of A. Gilbert & Cook Inc. raised its position in Agilent Technologies by 12.5% during the 4th quarter. Gilbert & Cook Inc. now owns 2,872 shares of the medical research company’s stock worth $399,000 after purchasing an additional 320 shares during the last quarter. Cambridge Investment Research Advisors Inc. raised its position in shares of Agilent Technologies by 6.8% in the 4th quarter. Cambridge Investment Research Advisors Inc. now owns 12,621 shares of the medical research company’s stock worth $1,755,000 after acquiring an additional 807 shares in the last quarter. Orion Portfolio Solutions LLC raised its position in shares of Agilent Technologies by 19.2% in the 4th quarter. Orion Portfolio Solutions LLC now owns 11,033 shares of the medical research company’s stock worth $1,472,000 after acquiring an additional 1,774 shares in the last quarter. Stifel Financial Corp raised its position in shares of Agilent Technologies by 9.6% in the 4th quarter. Stifel Financial Corp now owns 131,080 shares of the medical research company’s stock worth $18,229,000 after acquiring an additional 11,498 shares in the last quarter. Finally, California State Teachers Retirement System raised its position in shares of Agilent Technologies by 1.0% in the 4th quarter. California State Teachers Retirement System now owns 469,486 shares of the medical research company’s stock worth $65,273,000 after acquiring an additional 4,788 shares in the last quarter. 87.42% of the stock is owned by institutional investors.

Insider Transactions at Agilent Technologies

In other news, CEO Padraig Mcdonnell sold 1,958 shares of the business’s stock in a transaction that occurred on Friday, July 26th. The stock was sold at an average price of $140.00, for a total value of $274,120.00. Following the transaction, the chief executive officer now owns 26,076 shares in the company, valued at approximately $3,650,640. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. In other news, CEO Padraig Mcdonnell sold 1,958 shares of the business’s stock in a transaction that occurred on Friday, July 26th. The stock was sold at an average price of $140.00, for a total value of $274,120.00. Following the transaction, the chief executive officer now owns 26,076 shares in the company, valued at approximately $3,650,640. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, SVP Dominique Grau sold 9,990 shares of the business’s stock in a transaction that occurred on Thursday, September 26th. The stock was sold at an average price of $145.00, for a total value of $1,448,550.00. Following the completion of the transaction, the senior vice president now owns 40,011 shares in the company, valued at approximately $5,801,595. The disclosure for this sale can be found here. Insiders have sold 13,906 shares of company stock worth $2,006,580 in the last 90 days. Insiders own 0.33% of the company’s stock.

Analyst Ratings Changes

Several research analysts have recently weighed in on the company. Citigroup lifted their price objective on Agilent Technologies from $150.00 to $165.00 and gave the stock a “buy” rating in a research report on Thursday, August 22nd. TD Cowen lifted their price objective on Agilent Technologies from $153.00 to $160.00 and gave the stock a “buy” rating in a research report on Thursday, August 22nd. Jefferies Financial Group reissued a “hold” rating and issued a $135.00 price objective (down from $152.00) on shares of Agilent Technologies in a research report on Monday, June 3rd. Wolfe Research lowered Agilent Technologies from an “outperform” rating to a “peer perform” rating in a research report on Thursday, June 27th. Finally, Wells Fargo & Company assumed coverage on Agilent Technologies in a research report on Tuesday, August 27th. They issued an “overweight” rating and a $157.00 target price for the company. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and nine have given a buy rating to the company. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $142.93.

Agilent Technologies Price Performance

A stock opened at $148.06 on Monday. The company has a market capitalization of $43.20 billion, a P/E ratio of 35.00, a price-to-earnings-growth ratio of 6.48 and a beta of 1.05. The company has a debt-to-equity ratio of 0.36, a quick ratio of 1.37 and a current ratio of 1.78. Agilent Technologies, Inc. has a 52-week low of $96.80 and a 52-week high of $155.35. The business has a 50-day simple moving average of $138.91 and a two-hundred day simple moving average of $138.99.

Agilent Technologies (NYSE:A) last released its quarterly earnings results on Wednesday, August 21st. The medical research company reported $1.32 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.26 by $0.06. The business had revenue of $1.58 billion during the quarter, compared to the consensus estimate of $1.56 billion. Agilent Technologies had a return on equity of 25.26% and a net margin of 21.75%. The company’s quarterly revenue was down 5.6% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.43 EPS. Research analysts expect that Agilent Technologies, Inc. will post 5.24 EPS for the current fiscal year.

Agilent Technologies Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Wednesday, October 23rd. Shareholders of record on Tuesday, October 1st will be paid a dividend of $0.236 per share. The ex-dividend date is Tuesday, October 1st. This represents a $0.94 dividend on an annualized basis and a yield of 0.64%. Agilent Technologies’s dividend payout ratio (DPR) is currently 22.22%.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.